glp-1 agonist anxiety side effects An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders Ozempic and other GLP-1 drugs

Read the guide Medicare basics A plain-English breakdown of what each Medicare part covers, what it costs, and how they fit together for Washington State beneficiaries

More dietary consistency

Research on contestants from The Biggest Loser showed metabolic suppression lasting at least six years after their weight loss

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated superior efficacy for weight reduction and improved metabolic health compared with single GLP-1 agonists

This brief examines the financialized business model of Novo Nordisk and Eli Lilly for the leading GLP-1 products Ozempic, Rybelsus, and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)